FOXP3 and cancer: FOXP3 induction was titratable, in that increasing the dose of cancer supernatant from 12.5 to 25%, and again to 50% of the total culture media leads to greater increases in FOXP3 expression in the naïve T cells, particularly for supernatants representing colon cancers (Fig. 1c).